Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.

Lee JH, Jahrling JB, Denner L, Dineley KT.

J Alzheimers Dis. 2018;64(s1):S427-S453. doi: 10.3233/JAD-179923.

PMID:
29710715
2.

Corrigendum to "Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease" [Neurobiol. Aging 58 (2017) 1-13].

Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT.

Neurobiol Aging. 2018 May;65:235-238. doi: 10.1016/j.neurobiolaging.2018.02.010. No abstract available.

PMID:
29580440
3.

The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent.

Acharya KD, Nettles SA, Sellers KJ, Im DD, Harling M, Pattanayak C, Vardar-Ulu D, Lichti CF, Huang S, Edwards DP, Srivastava DP, Denner L, Tetel MJ.

eNeuro. 2017 Sep 20;4(5). pii: ENEURO.0272-17.2017. doi: 10.1523/ENEURO.0272-17.2017. eCollection 2017 Sep-Oct.

4.

Corrigendum to "Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease" [Neurobiol. Aging 58 (2017) 1-13].

Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT.

Neurobiol Aging. 2017 Oct;58:241. doi: 10.1016/j.neurobiolaging.2017.08.011. No abstract available.

PMID:
28863813
5.

Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.

Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT.

Neurobiol Aging. 2017 Oct;58:1-13. doi: 10.1016/j.neurobiolaging.2017.06.003. Epub 2017 Jun 17. Erratum in: Neurobiol Aging. 2018 May;65:235-238. Neurobiol Aging. 2017 Oct;58:241.

6.

PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Hsu WJ, Wildburger NC, Haidacher SJ, Nenov MN, Folorunso O, Singh AK, Chesson BC, Franklin WF, Cortez I, Sadygov RG, Dineley KT, Rudra JS, Taglialatela G, Lichti CF, Denner L, Laezza F.

Exp Neurol. 2017 Sep;295:1-17. doi: 10.1016/j.expneurol.2017.05.005. Epub 2017 May 15.

7.

PPARγ agonism attenuates cocaine cue reactivity.

Miller WR, Fox RG, Stutz SJ, Lane SD, Denner L, Cunningham KA, Dineley KT.

Addict Biol. 2018 Jan;23(1):55-68. doi: 10.1111/adb.12471. Epub 2016 Nov 11.

8.

Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.

Mustafa GM, Larry D, Petersen JR, Elferink CJ.

World J Hepatol. 2015 Jun 8;7(10):1312-24. doi: 10.4254/wjh.v7.i10.1312. Review.

9.

Impaired firing properties of dentate granule neurons in an Alzheimer's disease animal model are rescued by PPARγ agonism.

Nenov MN, Tempia F, Denner L, Dineley KT, Laezza F.

J Neurophysiol. 2015 Mar 15;113(6):1712-26. doi: 10.1152/jn.00419.2014. Epub 2014 Dec 24.

10.

Insulin resistance in Alzheimer's disease.

Dineley KT, Jahrling JB, Denner L.

Neurobiol Dis. 2014 Dec;72 Pt A:92-103. doi: 10.1016/j.nbd.2014.09.001. Epub 2014 Sep 16. Review.

11.

PPARγ recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement.

Jahrling JB, Hernandez CM, Denner L, Dineley KT.

J Neurosci. 2014 Mar 12;34(11):4054-63. doi: 10.1523/JNEUROSCI.4024-13.2014.

12.

Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Nenov MN, Laezza F, Haidacher SJ, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Dineley KT, Denner L.

J Neurosci. 2014 Jan 15;34(3):1028-36. doi: 10.1523/JNEUROSCI.3413-13.2014.

13.

Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.

Mustafa MG, Petersen JR, Ju H, Cicalese L, Snyder N, Haidacher SJ, Denner L, Elferink C.

Mol Cell Proteomics. 2013 Dec;12(12):3640-52. doi: 10.1074/mcp.M113.031252. Epub 2013 Sep 5.

14.

Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways.

Denner LA, Rodriguez-Rivera J, Haidacher SJ, Jahrling JB, Carmical JR, Hernandez CM, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Wood TG, Dineley KT.

J Neurosci. 2012 Nov 21;32(47):16725-35a. doi: 10.1523/JNEUROSCI.2153-12.2012.

15.

Detection of structural and metabolic changes in traumatically injured hippocampus by quantitative differential proteomics.

Wu P, Zhao Y, Haidacher SJ, Wang E, Parsley MO, Gao J, Sadygov RG, Starkey JM, Luxon BA, Spratt H, Dewitt DS, Prough DS, Denner L.

J Neurotrauma. 2013 May 1;30(9):775-88. doi: 10.1089/neu.2012.2391. Epub 2012 Sep 20.

16.

Molecular mechanisms underlying effects of neural stem cells against traumatic axonal injury.

Wang E, Gao J, Yang Q, Parsley MO, Dunn TJ, Zhang L, DeWitt DS, Denner L, Prough DS, Wu P.

J Neurotrauma. 2012 Jan 20;29(2):295-312. doi: 10.1089/neu.2011.2043. Epub 2011 Dec 23.

PMID:
22077363
17.

The simplest method for in vitro β-cell production from human adult stem cells.

Bhandari DR, Seo KW, Sun B, Seo MS, Kim HS, Seo YJ, Marcin J, Forraz N, Roy HL, Larry D, Colin M, Kang KS.

Differentiation. 2011 Oct;82(3):144-52. doi: 10.1016/j.diff.2011.06.003. Epub 2011 Jul 22.

PMID:
21782317
18.
19.

Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.

Rodriguez-Rivera J, Denner L, Dineley KT.

Behav Brain Res. 2011 Jan 1;216(1):255-61. doi: 10.1016/j.bbr.2010.08.002. Epub 2010 Aug 13.

20.

Using power spectrum analysis to evaluate (18)O-water labeling data acquired from low resolution mass spectrometers.

Sadygov RG, Zhao Y, Haidacher SJ, Starkey JM, Tilton RG, Denner L.

J Proteome Res. 2010 Aug 6;9(8):4306-12. doi: 10.1021/pr100642q.

Supplemental Content

Loading ...
Support Center